We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medican Enterprises Inc (PK) | USOTC:MDCN | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.000001 | 0.0001 | 0.0001 | 0.000001 | 0.0001 | 18,840,000 | 14:48:38 |
SEC FILE NUMBER:
|
000-53408
|
CUSIP NUMBER:
|
56464T
|
(Check One):
|
x
|
Form 10-K
|
o
|
Form 20-F
|
o
|
Form 11-K
|
o
|
Form 10-Q
|
o
|
Form N-SAR
|
o
|
Form N-CSR
|
o
|
Transition Report on Form 10-K
|
|
o
|
Transition Report on Form 20-F
|
|
o
|
Transition Report on Form 11-K
|
|
o
|
Transition Report on Form 10-Q
|
|
o
|
Transition Report on Form N-SAR
|
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
|
Medican Enterprises, Inc.
Full Name of Registrant
|
Former Name if Applicable
|
3440 E. Russell Road
Address of Principal Executive Office (Street and Number)
|
Las Vegas, NV 89120
City, State and Zip Code
|
x
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
x
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
o
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
(1)
|
Name and telephone number of person to contact in regard to this notification
|
Kenneth Williams
|
(800)
|
416-8802
|
||||
(Name)
|
(Area Code)
|
(Telephone Number)
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
|
Yes
|
x
|
No
|
o
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
Yes
|
o
|
No
|
x
|
Medican Enterprises, Inc.
(Name of Registrant as Specified in Charter)
|
Date: March 25, 2015
|
By: /s/ Kenneth Williams
|
|
Kenneth Williams, Chief Executive Officer and Director
|
Director
|
1 Year Medican Enterprises (PK) Chart |
1 Month Medican Enterprises (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions